Prospective, Single-Center, Open-Label, Pilot Study Using Cryopreserved Umbilical Tissue Containing Viable Cells in the Treatment of Complex Acute and Chronic Wounds

Robert F. Mullins, MD; Zaheed Hassan, MD; Bounthavy Homsombath, MD; Shawn Fagan, MD; Beretta Craft-Coffman, PA-C; Joan Wilson, MSN, MHA, RN; John G. Rumbaugh, MD; Molly Saunders, BS; Alla Danilkovitch, PhD

Disclosures

Wounds. 2020;32(8):221-227. 

In This Article

Limitations

The present study is not without its limitations, with the main one being the small sample size and the lack of a control arm. Additionally, a longer study duration of either 12 weeks or 16 weeks would be needed to accurately assess closure outcomes.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....